BHG Colorado Springs Treatment Center is a licensed substance use treatment provider in Colorado Springs, CO, listed in the SAMHSA treatment directory. Outpatient care is offered, so clients can keep living at home between scheduled sessions. Methadone is available as part of medication assisted treatment for opioid use disorder. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting Medicaid. Private health insurance is accepted. It serves children/adolescents, young adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Levels of care
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatment
Type of care
Substance use treatmentTreatment for co-occurring disorders plus serious mental illness (SMI) in adultsTreatment for co-occurring disorders plus serious emotional disturbance (SED) in children
Medications
Methadone used in TreatmentBuprenorphine used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidPrivate health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Children/AdolescentsYoung AdultsSeniors
Accreditation
State substance use treatment agencyThe Joint CommissionFederally Qualified Health CenterSAMHSA certification for opioid treatment program (OTP)Drug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
5731 North Academy Boulevard, Colorado Springs, CO 80918
OutpatientOutpatient detoxificationOutpatient day treatment or partial hospitalizationIHS/Tribal/Urban (ITU) fundsFederal military insurance (e.g., TRICARE)
5360 North Academy Boulevard, Suite 290, Colorado Springs, CO 80918
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare